Market Indices


Latest News

Citigroup analyst issues OUTPERFORM recommendation for PGEN on May 14,...

May 14, 2026   PGEN 1.72%

Key Points
- Securities class action lawsuit filed against Gossamer Bio, Inc....

May 13, 2026   GOSS 0.88%

Aqua Metals, Inc. (AQMS) - This analysis reviews how the stock...

May 13, 2026   AQMS 2.66%

Xos Equity Warrants (XOSWW) - This analysis reviews how the stock...

May 13, 2026   XOSWW 8.33%


Price Targets

from Barrington issued a price target of $62.00 for APEI on 2026-05-13 16:50:21.The adjusted price target was set to $62.00.At the time of the announcement, APEI was...

May 13, 2026   APEI -0.17%

from Truist Financial issued a price target of $715.00 for PRAX on 2026-05-13 13:43:18.The adjusted price target was set to $715.00.At the time of the announcement, PRAX...

May 13, 2026   PRAX 1.06%

from UBS issued a price target of $10.00 for OPRX on 2026-05-13 13:26:23.The adjusted price target was set to $10.00.At the time of the announcement, OPRX was...

May 13, 2026   OPRX -22.48%

from Lake Street issued a price target of $7.00 for KOPN on 2026-05-13 12:54:21.The adjusted price target was set to $7.00.At the time of the announcement, KOPN...

May 13, 2026   KOPN -6.17%

from Lake Street issued a price target of $11.00 for OPRX on 2026-05-13 12:49:22.The adjusted price target was set to $11.00.At the time of the announcement, OPRX...

May 13, 2026   OPRX -22.48%



Market Movers

Top Gainers (%)
ARBEW
Arbe Robotics Ltd. Warran
0.06
41.54%
HYLN
Hyliion Holdings Corp.
3.58
33.15%
MOVE
Corvex, Inc.
19.25
27.57%
NOTV
Inotiv, Inc.
0.31
27.18%
GWH
ESS Tech, Inc.
0.98
26.70%
OUST
Ouster, Inc.
34.17
26.09%
ORGNW
Origin Materials Inc Warr
0.00
25.00%
PDSB
PDS Biotechnology Corpora
1.33
20.91%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP 9.62%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE 2.22%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK -2.43%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN -1.09%